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Insulin resistance and type II diabetes mellitus are major public health issues in 
the U.S.; more specifically insulin resistance is strongly correlated with obesity.  Multiple 
factors influence insulin resistance such as hyperglycemic conditions and increased 
levels of reactive oxygen species (ROS).  As oxygen radicals accumulate in adipocytes 
from increased glucose oxidation, they interfere with insulin signaling and affect glucose 
uptake.  To determine if insulin sensitivity can be prolonged with the aid of antioxidants, 
adipocytes were maintained in a high glucose medium supplemented with antioxidants 
ascorbic acid or α-tocopherol and then tested for insulin sensitivity.  Our studies reveal 
that ROS levels fluctuate in insulin resistant adipocytes (Day 11-21).  We show for the 
first time that there is a decrease in ROS levels at Day 13, which then significantly 
increase at Day 15 and this trend continues every other day till Day 21.  At Day 10 and 
15 the ROS levels are high, but adipocytes have high GLUT4 expression at Day 10 and 
decreased expression on Day 15.  By Day 15 there is increased phosphorylation of AKT 
but no change in IRS-1 phosphorylation.  The levels of ROS were significantly 
decreased with the application of antioxidants.  With decreased ROS levels there was 
overall increased phosphorylation of IRS-1 and AKT. The lipid content and distribution 
was not affected by ROS levels.  In conclusion, the development of insulin resistance is 
effected by ROS, however the data indicates that there is a mechanism independent of 
AKT, or a target downstream of AKT that is affected and leading to the development of 
insulin resistance.  ROS levels also regulate the expression of GLUT4 and thus GLUT4-
mediated glucose uptake resulting in resistance to insulin signaling.  Insulin resistance is 
affected by ROS levels differently if it is added exogenously, or if it is amassed 
endogenously.  Identification of factors that interfere with insulin signaling and thus type 
II diabetes, like ROS levels, can lead to the development of possible therapeutic 
treatments. 
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CHAPTER I 
INTRODUCTION 
 
 
Background 
 Approximately one third of the adult population in the U.S. is clinically obese 1.  
Even more alarming is that nearly 20% of the adolescent population is also obese 2.  
Obesity-associated health problems such as type II diabetes mellitus, heart disease, 
high cholesterol, and various cancers have made obesity the seventh leading cause of 
death in the U.S. 1.  Obesity is not only a leading public health issue but also a major 
economic issue costing the U.S. $147 billion in 2008 3.  One of the major obesity-
associated diseases is type II diabetes; of patients with type II diabetes, 90% are 
clinically overweight 4.  The hallmark of type II diabetes is that the body stops responding 
to insulin.  As a key hormone regulator of energy homeostasis, insulin signals adipose 
and skeletal muscle tissue to uptake excess glucose from the blood.  When adipocytes 
are constantly exposed to hyperglycemic conditions, excess energy is stored as 
triacylgycerol in increasing numbers and size of lipid droplets.  As adipocytes continue to 
increase their triacylglycerol content, they increases in size, and can stop responding to 
insulin signaling thus stopping insulin stimulated glucose uptake.  Without insulin 
stimulated glucose uptake into adipocyte and muscle tissues, plasma glucose levels 
remain chronically high, leading to the development of diabetes. 
Glucose Uptake and Storage in Adipocytes 
Numerous studies investigating insulin resistance have utilized the 3T3-L1 
adipocyte cell culture model.  3T3-L1 preadipocytes are murine embryonic fibroblasts 
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that can be induced to differentiate into mature adipocytes.  During differentiation the 
first lipid vacuoles form, once adipocytes are fully differentiated they contain many lipid 
vacuoles.  After prolonged exposure to glucose the lipid droplets form and begin to 
coalesce into a unilocular fat droplet that pushes the nucleus towards the plasma 
membrane, giving it a “signet-ring” structure.   
 In the body, high glucose concentrations are sensed by pancreatic β-cells 
resulting in increased insulin secretion.  Insulin stimulates adipose and muscle tissue to 
uptake glucose from the blood to lower the plasma glucose concentration back to normal 
levels.  Insulin resistance develops when cells are constantly exposed to hyperglycemic 
conditions.  Insulin resistance is a precursor to type II diabetes and occurs when the 
cells that respond to insulin require a higher concentration of insulin to stimulate glucose 
uptake. 
Insulin stimulated glucose transport into adipose tissue is a crucial function of 
insulin signaling.  Insulin binds to its tyrosine kinase receptor causing 
autophosphorylation of intrinsic tyrosine residues.  The phosphorylated tyrosine residues 
recruit and phosphorylate insulin receptor substrate-1 (IRS-1) on tyrosine residues 
(Y608/632 in mouse, Y612/632 in humans), activating mitogen-activated protein kinase 
(MAPK) and phosphoinositide 3-kinase (PI3K) pathways 5,6.  Specifically, PI3K catalyzes 
the formation of phosphatidylinositol-3, 4, 5-triphosphate (PIP3), which is the allosteric 
activator of phosphoinositide-dependent kinase (PDK).  PDK activates AKT and PKC 
stimulating translocation of the insulin responsive glucose transporter 4 (GLUT4) to the 
plasma membrane. The presence of GLUT4 in the plasma membrane facilitates glucose 
transport into the cell.   
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Activation of AKT is critical to glucose uptake and plasma glucose homeostasis.  
Adipocytes chronically exposed to high glucose levels stop responding to insulin and 
become insulin resistant.  In high glucose concentrations adipocytes have lower AKT 
phosphorylation than those in lower glucose concentrations 7.  With lower AKT 
phosphorylation, GLUT4 translocation and glucose uptake are down regulated in 
hyperglycemic conditions 7.  Also, in high glucose or high insulin conditions it has been 
observed that there are decreased levels of GLUT4 either due to down regulation of 
gene transcription or post translational control of GLUT4 as insulin resistance occurs; 
decreased expression is coupled with desensitization of 3T3-L1 to insulin stimulated 
glucose uptake 8. 
Oxidative Stress 
Many factors influence the insulin signaling pathway, one of which is oxidative 
stress.  Oxidative stress occurs when the rate at which reactive oxygen species (ROS) 
are generated exceeds the cell’s capacity to scavenge them.  Increased levels of ROS 
are associated with obesity and are produced during adipocyte differentiation 9.  ROS 
are generated in response to growth factors and cytokines and act as natural messenger 
molecules, especially as a part of the proinflammatory responses; however this function 
is newly realized and not well understood 10,11.  ROS are predominantly produced by 
oxidative phosphorylation in the mitochondria and have been suggested as a stimulant 
in the progression of insulin resistance and diabetes.  Most ROS are produced in the 
mitochondria during respiration in mitochondrial complexes I and III 12.  It has been 
shown that as adipocytes increase in size, the concentration of ROS increases in 3T3-L1 
adipocytes 13.  An increase in glucose, insulin, or free fatty acids can stimulate increased 
ROS production.  Examples of ROS produced during glucose oxidation are the 
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superoxide anion (O2●-), hydrogen peroxide (H2O2), and the peroxyl radical (OH●-) 
(figure 1) 14.  Accumulation of ROS can be detrimental to the health of the cell, but can 
also serve as part of necessary functions in the physiology of the cell, such as the 
inflammatory response.  ROS are radical forms of oxygen that readily react with, and 
cause damage to, cellular machinery, lipids, and nucleic acids 15.   
Adaptive stress response pathways are naturally in place to combat the adverse 
effects of ROS.  Typically, oxygen is used as the terminal electron acceptor in the 
electron transport chain in oxidative phosphorylation; on occasion it is not combined with 
hydrogen, but instead accepts an electron and becomes O2●-.  The enzyme superoxide 
dismutase (SOD) is produced in the cell to regulate the levels of O2●-, it does this by 
catalyzing the conversion of O2●- into H2O2 (figure 1); H2O2 has the ability to diffuse 
through cellular membranes and is less reactive than O2●- 11.  Finally, catalase or 
glutathione peroxidase transforms H2O2 into water, rendering the radical O2●- inert 
(figure 1).  Increased ROS production stimulates the activity of glutathione peroxidase, 
oxidizing H2O2 to water and thereby reducing glutathione from its oxidized form (GSH) 
to its reduced form (GSSG) (figure 1).  Glutathione reductase then oxidizes NADPH to 
NADP+ and oxidizes glutathione back to GSH.  NAD(P)H oxidase is another source of 
ROS production that attracts and stimulates macrophages in obese patients, causing 
injury to surrounding tissues 16.  Other sources of ROS production include the p450 
system, cytosolic enzymes and transition metals.  Though present in bacteria and fungi, 
glucose oxidase is not produced in humans or murine adipocytes and does not 
contribute to the ROS in 3T3-L1 adipocytes 17. 
In cases of hyperglycemia, oxidative phosphorylation occurs at higher rates, 
inadvertently producing higher amounts of O2●-, and thus higher amounts of ROS.  The 
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amplified concentration of ROS affects insulin stimulated glucose transport.  In 
hyperglycemic conditions the production of ROS during differentiation increases both in 
vivo and in vitro 7,18.  Studies have shown that when adipocytes become insulin resistant 
they produce and accumulate lower amounts of ROS, suggesting that with less glucose 
uptake, there is a lower production of ROS 7. 
Production and accumulation of ROS naturally occurs in adipocytes exposed to 
chronic high glucose conditions and occurs before the onset of insulin resistance 13-15.  
Oxidative stress may play a causative role in insulin resistance because increased 
oxidative stress is a precursor to insulin resistance; yet, the direct role of oxidative stress 
is unknown 15.  Likewise, chronic insulin treatment, mimicking the necessity of higher 
insulin concentrations due to increased plasma glucose levels for insulin stimulated 
glucose uptake, has been found to increase intracellular O2●-, H2O2, and OH●- in 3T3-L1 
cells 19.  Once 3T3-L1 preadipocytes differentiate into mature adipocytes, there is 
insufficient data on the effects of ROS on the development of insulin resistance and how 
adipocytes deal with this stress.  Insulin stimulates increased glucose uptake and thus 
increased cellular respiration and O2●- levels.  If ROS play a major role in insulin 
resistance it may be possible to maintain insulin sensitivity if ROS are scavenged.   
Antioxidant Function 
Intrinsically, adipocytes counteract oxidative stress by inducing the activity of 
antioxidant enzymes like glutathione peroxidase, glutathione reductase, SOD, and 
catalase (figure 1).  Adipocytes are also able to utilize antioxidant dietary compounds 
and vitamins to aid in the control of oxidative stress.  Both ascorbic acid and alpha-
tocopherol are dietary compounds known to function as antioxidants intrinsically through 
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the same endogenous pathways the cell uses to scavenge O2●-, H2O2, and OH●- (figure 
1).   
L-ascorbic acid (vitamin C) is a water soluble vitamin that has antioxidant 
properties.  In liver cells exhibiting ischemia, the addition of ascorbic acid causes an 
increase in SOD and glutathione activity 20.  Vitamin C is especially useful in antioxidant 
functions because of its ability to regenerate antioxidants like catalase, glutathione 
peroxidase, and α-tocopherol (vitamin E) by accepting the free electron and converting 
from ascorbic acid into dehydroascorbate, which then breaks down 21,22.  L-ascorbic acid 
and its reduced counterpart, dehydroascorbate, can be transported into a cell via simple 
diffusion, facilitated diffusion, and active transport mechanisms 23.  There is little 
research on the known natural antioxidant vitamin C and its effects on insulin sensitivity 
in 3T3-L1 adipocytes.   
Alpha-tocopherol, or vitamin E, is a fat soluble vitamin that also is a phenolic 
antioxidant.  Vitamin E is stored in the lipid droplets of adipocytes.  Alpha-tocopherol 
scavenges unpaired electrons from H2O2 or lipid peroxyl radicals and mimics the action 
of glutathione peroxidase to diffuse the reactivity of these molecules.  Though vitamin E 
and C have different solubility’s, vitamin C has the ability to recycle vitamin E 22.  Vitamin 
E typically enters the cell enter the cell via the LDL receptor pathway 24. 
Effects of ROS on Insulin Stimulated Glucose Uptake 
Scavengers of ROS could potentially prevent insulin resistance and type II 
diabetes 9.  Many studies have examined the effects of ROS on insulin stimulated 
glucose uptake in adipocytes using exogenously applied ROS e.g. H2O2 (figure 2a).  
What has not been examined is the role of endogenously produced ROS on the 
development of insulin resistance (figure 2b).  Studies of exogenously added or applied 
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ROS have identified mechanistic effects of ROS on insulin stimulated glucose uptake.  
For instance, micro molar amounts of H2O2 applied to 3T3-L1 adipocytes were found to 
decrease insulin signaling and insulin mediated glucose metabolism 18,25.  Increased 
oxidative stress was also found to down regulate GLUT4 expression in 3T3-L1 
adipocytes 25,26.  High levels of ROS inhibited insulin signaling by causing 
phosphorylation of IRS-1 serine residues 27,28.  IRS-1 serine (S636) phosphorylation 
causes allosteric inhibition of the tyrosine residue phosphorylation and thus inhibition of 
IRS-1 activation by the insulin receptor 27-30.   
While previous studies have examined the role of exogenously added ROS, they 
have not investigated the impact of endogenously produced ROS.  ROS overproduction 
is stimulated by high plasma glucose concentrations before insulin resistance occurs.  
As cellular respiration rates increase, there are higher levels of O2●- produced.  The O2●- 
produced are scavenged by the adaptive stress response pathway.  O2●- radicals have a 
very short half-life of 0.05 seconds and are very reactive; measuring levels of O2●- will 
give the best measure of ROS levels in differentiated adipocytes 31.  Examining the 
relationship between the production of ROS by glucose oxidation and how it affects 
glucose uptake and insulin signaling will provide insight to better understand how ROS 
induces insulin resistance.   
Effects of Antioxidants on Insulin Stimulated Glucose Uptake 
The use of an antioxidant to alleviate ROS accumulation in 3T3-L1 adipocytes 
may help regain insulin sensitivity in insulin-resistant adipocytes.  One study found that 
applied antioxidants counteract the effects of exogenous H2O2 but do not affect the 
endogenous oxidative stress levels 32.  Another study found that by applying antioxidants 
that mimic the activity of glutathione and SOD prolonged insulin sensitivity and GLUT4 
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activity by 65% 15.  GLUT4 translocation and insulin sensitivity were also sustained in 
hyperglycemic conditions with the addition the antioxidants 33.  In these and other 
studies antioxidants have been found to block the effects of exogenous H2O2, however 
little work has been done to alleviate endogenous H2O2 production.  Antioxidants have 
only been shown to recover a portion of insulin sensitivity, but not full sensitivity 34.  The 
addition of antioxidants to insulin resistant 3T3-L1 adipocytes could also alleviate insulin 
resistance, increase insulin signaling, and increase glucose uptake.  With the 
antioxidants ascorbic acid and α-tocopherol, insulin-resistant 3T3-L1 adipocytes may 
maintain insulin sensitivity with added antioxidants in the presence of high glucose 
levels.  Antioxidant treatment of ascorbic acid or α-tocopherol have been used in clinical 
studies to examine their ability to recover insulin sensitivity in insulin resistant or type II 
diabetic individuals 35-38.  However, these studies are not comparable to our study as the 
antioxidants are being given to individuals that are already insulin resistant; we are 
interested in examining the maintenance of insulin sensitivity with decreased ROS levels 
in high glucose conditions and examining insulin signaling and sensitivity in this 
environment before the onset of insulin resistance; we are not treating insulin resistant 
adipocytes but insulin sensitive adipocytes to determine this effect. 
Lowering ROS levels, by adding antioxidants, may have a profound effect on 
insulin sensitivity in adipocytes.  Decreasing ROS accumulation, with antioxidants, may 
allow insulin-resistant 3T3-L1 adipocytes to regain insulin sensitivity. 
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CHAPTER II 
EXPERIMENTAL DESIGN (MATERIALS & METHODS) 
 
Materials 
 Dulbecco’s Modified Eagle’s Medium (DMEM) tissue culture media was from 
Gibco (#11995-073).  Serum supplements Bovine Calf Serum (#SH30072.03) and Fetal 
Bovine Serum (#SH30071.03) were from Hyclone.   Penicillin Streptomycin was 
purchased from Gibco (#15140122).  3-isobutyl-1-methylxanthine (MIX) (#101024374), 
dexamethasone (DEX) (#D4902), and insulin (#I5500) were obtained from Sigma-
Aldrich.  Trypsin-EDTA (1X) was from Gibco (#25300-054).  Protein Extraction Buffer 
was made with PICII (#P5726) and PICIII (#P0044) from Sigma-Aldrich.  Bovine Albumin 
(BSA) was obtained from MP Biomedical LLC (#810033).  Ascorbic acid was derived 
from FisherScientific (#BP351-500) and α-tocopherol from Sigma-Aldrich (#258024).  
Primary antibodies pAKT(S473) (#9271S), AKT (#9272S), and Pan-Actin (#4968) were 
acquired from Cell Signaling, pIRS-1 Tyr612 (#OPA1-03183) from ThermoScientific, 
anti-rat carboxy-term IRS-1 (#06-248) from Upstate Biotechnology Incorporated, pan-
actin from Celand Glut4 goat polyclonal (N-20) (#sc-1606) from Santa Cruz 
Biotechnology.   Secondary anti-rabbit IgG antibodies were from SIGMA (#A6154-1ML) 
and donkey anti-goat IgG-HRP from Sanya Cruz Biotechnology (#sc-2020).   The 
SuperSignal West Pico Stable Peroxide solution and SuperSignal West Pico 
Luminal/enhancer solutions were attained from ThermoScientific (#34077).  
Nitortetraxolium Blue chloride (NBT) was obtained from Sigma-Aldrich (#N6876).  
Phosphate Buffered Saline was obtained from FisherScientific (#BP399.500).  Guava 
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ViaCount Reagent for FLOW Cytometer was from EMD Millipore Corporation (#4000-
0040). 
Cell Culture 
Murine 3T3-L1 preadipocytes were grown to confluency in high glucose DMEM 
with 10% Bovine Calf Serum (BCS).  Forty-eight hs post confluency (Day 0) the 3T3-L1 
preadipocytes were induced to differentiate in high glucose DMEM containing PenStrep 
and 10% Fetal Bovine Serum (FBS) with 0.52 mM 3-isobutyl-1-methylxanthine, 1 µM 
dexamethasone, and 1.7 µM insulin.  On Day 4, the medium was changed to a high 
glucose DMEM, 10% FBS and 1 µM insulin.  The media was replaced every 2 days with 
DMEM-10% FBS. Cells were fed the day before being assayed.     
Antioxidant Treatment Groups 
Adipocytes were kept at a high glucose concentration and with added 
antioxidants α-tocopherol (40 µM) and ascorbic acid (60 µM) to the treatment groups 
from Day 7 through Day 15.   
NBT Assay 
 The nitroblue tetrazolium (NBT) assay is used to quantify ROS produced in cells, 
specifically to measure the amount of superoxide anions produced in cells.  NBT, a 
yellow solution, is membrane permeable and is reduced by the superoxide anion to 
formazan, a blue insoluble form of NBT.  3T3-L1 preadipocytes were differentiated.  At 
the time of NBT testing, cells were washed 3 times at room temperature with 1X PBS.  
NBT (0.2%) in 1X PBS or 1X PBS was applied to the experimental and control samples 
respectively.  The treated cells were incubated at 37˚C and 5% CO2 for 90 min.  
Following incubation, the treatments were aspirated and trypsin was added to cells for 
60 sec.  The cell suspension was centrifuged at 1400 rpm for 10 min.  The supernatant 
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was discarded and 50% acetic acid in 1X PBS was added.  Samples were sonicated.  
Samples were transferred to a 96 well plate and the absorbance was measured at 560 
nm 39-41. 
Total Protein Extraction 
3T3-L1 preadipocytes were differentiated, on Day 7 cells were treated with or 
without antioxidants.  For each treatment group at Days 10 and 15, cells were washed 
twice with 1X PBS.  Following the washes, Pessin protein lysis buffer (616 µL dH2O, 70 
µL protease inhibitor (10X), 7 µL PICII and 7 µL PICIII) was prepared and added to cells. 
The cell extract was rocked for 20 min at 4˚C.  Following rocking, the extract was 
centrifuged for 20 min at 6000 rpm at 4˚C. After centrifuging, the protein extract was 
removed and stored at -20˚C.   
Immunoblotting 
 Approximately 20-30 µg protein extract was subjected to SDS-PAGE.  After 
electrophoresis, the proteins were transferred to Immobilon filters.  The Immobilon filter 
was incubated in 4% BSA in 1X Tris-Buffered Saline – Tween 20 (1X TTBS) (0.05 M tris, 
0.15 M NaCl, 1% Tween-20 at pH 7.5) for an h.  Primary antibodies were incubated with 
the Immoblion filter at a dilution of 1:1000 overnight at 4˚C.  The primary antibody was 
then removed and the Immobilon filter was washed 3 times at increments of 7 min each, 
using 1X TTBS.  A secondary antibody was then used at a 1:2000 dilution in 1X TTBS 
for 45 min.  After 45 min, the Immobilon filter was washed 3 times at 7 min increments in 
1X TTBS. 
Enzymatic Chemiluminescence (ECL) 
 The SuperSignal West Pico kit was used to detect specific proteins on the 
Immobilon filter and imaged on the Bio-Rad ChemiDoc XRS imaging station. 
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Cell Viability Assay on FLOW Cytometer 
 3T3-L1 adipocytes were grown to confluency and treated as described above.  At 
Days 10 and 15 cells were harvested using trypsin.  Equal volumes of media was added 
to stop trypsionization of cells and the suspension was centrifuged at 5 for 5 minutes.  
The supernatant was removed and the cells were resuspended in 500 µL of 1X PBS.  A 
1:20 dilution was made with the Guava ViaCount Reagent.  Samples were vortexed and 
placed in the dark for 5 minutes and then assayed by flow cytometry.   
Quantification of Lipid Droplets  
 Day 10 and 15 unstained adipocytes were imaged on an AMG EVOSxl imaging 
station using phase contrast microscopy at 40X and 100X.  Lipid droplet diameters from 
20 adipocytes per day, per treatment were counted and categorized by size on both Day 
10 and 15.  The diameter size categories measured were <6.25um, 6.25-12.5um, 12.5-
25um, and >25um.  The percent distribution of lipid droplets by size was calculated. 
Statistical Analysis 
Data are represented as ± standard deviation of at least three independent 
experiments.  Student’s t-test was used for statistical analysis.  Differences were 
considered statistically significant at p < 0.05. 
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CHAPTER III 
RESULTS 
 
ROS Levels Fluctuate After the Onset of Insulin Resistance  
Previous studies have shown that initially there is an increase in ROS from Day 0 
to 7 while differentiation occurs; however, little is known about the ROS levels in 
differentiated adipocytes as they become insulin resistant.  The NBT assay was utilized 
to determine the levels of ROS produced in mature adipocytes.  NBT is able to diffuse 
through the cell membrane and react with the superoxide anion to form formazan (a blue 
precipitate).  In high glucose medium, increase cellular respiration occurs resulting in 
increased O2●- production; thus the NBT assay was optimal to measure O2●- levels as a 
representative sample of ROS levels in mature adipocytes. ROS levels were measured 
using the NBT assay every other day, from Day 7 through Day 21.  As seen in figure 3, 
after differentiation, adipocytes produce relatively high levels of ROS (Day 7-11).  While 
ROS levels remain fairly constant when adipocytes are insulin sensitive (up to Day 10), 
after Day 11 ROS levels fluctuate from low to high every other day (figure 3).  At Day 13 
ROS levels decrease to about half the levels experienced after differentiation on Day 10.  
The ROS then increase back to levels present in insulin sensitive adipocytes within two 
days.  This significant rise in ROS indicates that adipocytes are experiencing oxidative 
stress and may be a major factor promoting insulin resistance.  This experiment was 
repeated three times and a consistent flux of ROS levels was observed each time.  
These findings suggest that after Day 11 (at a time point when adipocytes are sensitive 
to insulin) ROS levels are not stable and may indicate the onset of insulin resistance. 
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Determination of Antioxidant Treatment Concentrations 
Previous studies have shown that antioxidant treatment can decrease high levels 
of ROS.  Thus we wanted to determine if antioxidants could reduce the high levels of 
endogenous ROS produced in insulin sensitive and resistant cells.  To determine the 
effects of antioxidants on insulin resistant adipocytes we used two well characterized 
antioxidants, ascorbic acid and α-tocopherol.  To determine the optimal concentration of 
ascorbic acid and α-tocopherol required to reduce ROS levels in differentiated 
adipocytes, we tested concentrations used previously for differentiating adipocytes 42,43.  
Thus, we assayed ROS levels at various antioxidant concentrations in insulin sensitive 
(Day 10) and insulin resistant (Day 15) adipocytes.  Starting on Day 7 adipocytes were 
treated with varying ascorbic acid or α-tocopherol concentrations in dH2O and DMSO 
respectively until Day 10 or 15.  A viability assay was performed to verify that the vehicle 
or antioxidant concentrations were not detrimental to cell viability.  We found that 
increasing concentrations of ascorbic acid or α-tocopherol had no effect on cell viability 
(figure 4a, b).  As seen in figure 4c the ascorbic acid concentration (60 µM) used 
previously in differentiating adipocytes was sufficient to significantly lower ROS levels in 
mature adipocytes compared to both untreated and vehicle (dH2O) treated adipocytes.  
ROS levels were significantly decreased at 60 μM ascorbic acid to approximately the 
same levels as high concentrations.  Concentrations higher than 60 µM elicited no 
further reduction of ROS, and at Day 15 actually enhanced the ROS production at the 
high concentration of 500 µM (figure 4c).  The optimal α-tocopherol concentration 
utilized on differentiating adipocytes (40 µM) was shown to be ample enough to 
significantly reduce ROS levels in mature adipocytes compared to both untreated and 
vehicle (DMSO) treated adipocytes (figure 4d).  Increasing concentrations of α-
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tocopherol concentrations did not further enhance the reduction of ROS (figure 4d). 
Therefore, concentrations of ascorbic acid treatments used from this point forward are 
60 µM, while the concentration of α-tocopherol is 40 µM.  As seen in figure 4c and 4d, 
we used antioxidant concentrations that were used previously on differentiating 
adipocytes. 
Antioxidant Treatment Decreases ROS Levels  
To determine the effectiveness of the antioxidants in adipocytes, the levels of 
ROS on Days 10 and 15 were determined in the presence and absence of antioxidant 
concentrations optimized previously.  Ascorbic acid treatment significantly decreased 
ROS levels in both Day 10 and 15 adipocytes to levels significantly lower than those 
seen during the flux period (figure 5).    A concentration of 60 µM ascorbic acid showed a 
significant decreased in ROS levels compared to untreated adipocytes at both Day 10 (p 
= 0.040) and at Day 15 (p = 0.023) (figure 5).  Similarly, α-tocopherol significantly 
decreased ROS levels to a greater extent than ascorbic acid at Day 10 (p = 0.004) and 
at Day 15 (p = 0.023) when compared to untreated cells (figure 5).  These findings 
indicate that since the levels of ROS are significantly lowered when compared to 
untreated cells, Day 10 and 15 adipocytes are not resistant to the effects of ascorbic 
acid and α-tocopherol (figure 5). 
Decreased ROS Levels do not Effect Lipid Accumulation  
While some studies have shown that ROS play a role in insulin resistance, other 
studies have implicated lipid droplet size as a factor in the development of insulin 
resistance.  As adipocytes are constantly maintained in high glucose conditions they 
intake glucose and gain lipid storage.  Day 10 adipocytes have numerous small lipid 
droplets and very few large droplets whereas Day 15 adipocytes have far more larger 
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droplets (figure 6). As lipid is accumulated in adipocytes the lipid droplets coalesce into 
larger droplets and render the cell resistant to insulin signaling 13.  As the lipid droplets 
increase in size and decrease in number inside adipocytes, the levels of ROS 
increase 13.  As expected, the majority of lipid droplets in Day 10 and 15 adipocytes are 
smaller than 6.25 μm in diameter (figure 7).  As droplets size increases the number of 
droplets diminishes, and the majority of droplets should be relatively small (<6.25 µm).  
As adipocytes gain lipid the ROS levels increase; they also become insulin resistant 9,13.  
What is unknown is the relationship between the size of lipid droplets in adipocytes and 
levels of ROS.  To determine this relationship we treated Day 7 adipocytes with 
antioxidants and measured lipid droplet diameter and distribution after 3 and 8 days of 
treatment (figure 7, table 1).  Of the cells counted, the number of cells containing each 
lipid droplet size range does not significantly differ between control and treatment groups 
on Day 10 or 15 (table 1).  Decreasing ROS using antioxidants should allow increased 
storage of lipid in adipocytes compared to untreated adipocytes.  Both ascorbic acid and 
α-tocopherol treatment did not change lipid accumulation on Day 10 or 15 compared to 
untreated cells (figure 6).  Based on the distribution of lipid droplets as well as the 
number of large droplets per cell, neither ascorbic acid nor α-tocopherol treatment 
altered lipid parameters. 
ROS Levels Alter GLUT4 Protein Expression 
 As adipocytes become larger and insulin resistant the expression of GLUT4, a 
key component in the insulin signaling pathway, is decreased.  Studies have shown that 
decreased GLUT4 expression is coupled with decreased insulin stimulated glucose 
uptake 44.  To verify that Day 10 adipocytes are insulin sensitive and Day 15 adipocytes 
are insulin resistant we assayed the levels of GLUT4.  A decrease in GLUT4 expression 
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would indicate that the cells have a decreased ability to take-up glucose.  Total protein 
was extracted and subject to a 10% SDS-PAGE; and subsequently immunoblotted with 
antibodies to GLUT4 and actin.  The expression of GLUT4 decreased from Day 10 to 15 
in untreated adipocytes as is seen in figure 8a.  The decrease in GLUT4 expression is 
indicative of decreased insulin sensitivity.  Adipocytes treated with antioxidants displayed 
increased expression of GLUT4 at Day 15 compared those that were untreated (figure 
8b-c).  Ascorbic acid treatment allows for equal GLUT4 expression on Days 10 and 15 
(figure 8b).  Similarly, α-tocopherol treatment allowed for equal or increased GLUT4 
expression (figure 8c).  Our results indicate that decreased ROS level allows for 
increased GLUT4 expression, and thus increased insulin sensitivity at Day 15. 
IRS-1 Activation  
 GLUT4 mediated glucose up-take requires activation of the insulin signaling 
pathway.  The primary substrate of the insulin receptor is IRS-1.  Using antioxidants to 
decrease ROS levels, IRS-1 phosphorylation status was evaluated by extracting and 
subjecting total proteins to a 6% SDS-PAGE, and preforming an immunoblot with 
antibodies to phosphorylated IRS-1, or with antibodies to total IRS-1.  As seen in figure 
9a, Day 10 adipocytes exhibit about a 6 fold increase in IRS-1 phosphorylation and a 5 
fold increase at Day 15, however this difference is not significant indicating that the 
stimulation of IRS-1 activation by insulin signaling is not affected by adipocyte age.  
When ROS levels were decreased, via treatment with antioxidants ascorbic acid or α-
tocopherol, the phosphorylation of IRS-1 increased both on Day 10 and 15 when 
normalized to the phosphorylation levels on each respective day without antioxidant 
treatment (figure 9b).  IRS-1 phosphorylation exhibited a higher fold increase on Days 10 
and 15 when treated with α-tocopherol compared with ascorbic acid.   Phosphorylation 
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of IRS-1 was not affected by adipocyte age as its status was increased equally on both 
days when treated with ascorbic acid or α-tocopherol.  Thus, our findings indicate that 
IRS-1 phosphorylation is not suppressed by high levels of ROS in Day 10 or 15 
adipocytes in contrast to studies by Lin et al. which used Day 8 and 12 adipocytes and 
saw decreased phosphorylation of IRS-1 as a result of increased ROS.  This may 
indicate that another signaling molecule in the insulin signaling cascade is potentially 
affected by ROS and hindering insulin sensitivity 7. 
AKT Activation  
 Insulin activated IRS-1 leads to the activation of AKT.  AKT is a key component 
of insulin stimulated glucose uptake; phosphorylation of AKT is a major component in 
mediating GLUT4 translocation 45.  At high glucose concentrations when adipocytes 
become insulin resistant the phosphorylation of AKT decreases 7.  Previous work has 
shown that when H2O2 is applied to insulin-sensitive adipocytes, the activation of AKT is 
inhibited 45.  AKT phosphorylation status was evaluated in the presence and absence of 
antioxidants by extracting and subjecting total proteins to a 10% SDS-PAGE, and 
immunoblot analysis with antibodies to phosphorylated AKT or total AKT.  As seen in 
figure 10a, Day 15 adipocytes have about a 10 fold increase in AKT activation compared 
to Day 10 adipocytes.  This may indicate that at Day 15 there is an underlying 
mechanism that functions to respond to insulin signaling as the cells become resistant.  
When ROS were decreased in adipocytes, via ascorbic acid or α-tocopherol treatment, 
the phosphorylation of AKT increases both on Day 10 and 15, but follows the trend seen 
in untreated cells of increasing phosphorylation of AKT at Day 15 compared to Day 10 
(figure 10).  AKT phosphorylation levels in the presence of antioxidants was normalized 
to AKT phosphorylation levels in insulin stimulated untreated adipocytes.  Our studies 
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indicate that AKT is not a primary target of ROS in adipocytes during the development of 
insulin resistance.   
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CHAPTER IV 
DISCUSSION 
   
 
Insulin resistance is a precursor of type II diabetes mellitus.  Hyperglycemic 
conditions induce high insulin concentrations in the blood and stimulate the insulin 
signaling cascade in adipose tissue initiating free radical formation through increased 
ATP production via glucose oxidation.  These high glucose conditions also lead to the 
onset of insulin resistance.   The role which ROS play in the development of insulin 
resistance may be protective, functioning to alleviate excess radical formation via 
glucose oxidation; it may also be a byproduct of increased glucose uptake and oxidation, 
adversely leading to insulin resistance.   
The majority of studies examine changes in insulin signaling in differentiating 
adipocytes, which encompasses Day 0 through Day 7, while adipocytes are extremely 
insulin sensitive. However, examining insulin sensitivity after Day 7 and its natural 
decline can provide insight into the development of disease states, like insulin 
resistance.  Once adipocytes are fully differentiated (Day 7) they respond to insulin 
signaling and grow in size but, over time, they lose insulin sensitivity approximately 
around Day 12.  Typically, most studies examining insulin sensitive events use Day 7 to 
10 adipocytes 46.  Very few studies have examined the insulin response in adipocytes 
after Day 10.  It is important to study adipocytes as they become insulin resistant to 
determine the factors, like ROS, that influence insulin signaling. 
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Adipocytes are insulin responsive and thus perform glucose uptake from Day 7 to 
Day 10 7,15,28.  After Day 10, insulin sensitivity and glucose uptake decline rapidly.  In 
insulin sensitive adipocytes (Day 7-10) GLUT4 expression is high allowing for good 
glucose uptake, however GLUT4 expression decreases by Day 15 indicating decreased 
glucose uptake and insulin resistance (figure 8a).  Day 10 and 15 adipocytes have equal 
phosphorylation of IRS-1 suggesting that the targets involved in insulin resistance are 
downstream of IRS-1 (figure 9a).  Surprisingly, AKT phosphorylation increases from Day 
10 to 15 indicating that an insulin independent mechanism is initiating phosphorylation of 
AKT at Day 15 when the adipocytes are insulin resistant (figure 10a).  This suggests that 
there is a complex regulatory mechanism.  It may be that while adipocytes are sensitive 
to insulin signaling, ROS regulate AKT phosphorylation, but after the destabilization of 
ROS levels, adipocytes become insulin resistant and there is a response mechanism in 
place to increase AKT activation.   
We also observed a novel trend in ROS levels from Day 7 to 21 as adipocytes 
lose insulin sensitivity.  The oscillating trend of ROS (figure 3) production after terminal 
differentiation was unexpected.  We are the first to show this pattern of ROS levels.  
Okada et al. 2010 observed lipid accumulation and ROS levels out to Day 28, but only 
looked periodically, at Day 8, 18, and 28; Okada et al. observed a significant decrease in 
ROS at each time point, but only looked at days where we observed a decline as well; 
they did not observe the intermediate increase in ROS every 4 days 47.  Because we 
monitored ROS levels every other day we were able to document the fluctuating levels 
of ROS.  This trend could be due to the onset of insulin resistance; as adipocytes 
become insulin resistant they may have a feedback mechanism to decrease both 
glucose uptake and ROS levels to alleviate stress on cells 13.  Also, the fluctuation in 
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ROS levels could be a result of the antioxidant response system in the adipocyte; when 
oxidative stress is experienced there is an increase in expression of antioxidant 
enzymes to compensate for the stress.  Alteration in the antioxidant response 
mechanism activating Nrf2 responsive gene transcription could account for this flux and 
should be investigated further.  The pattern of ROS levels suggests that there is a 
cycling of oxidative stress responses every few days in response to high glucose 
concentrations.  To determine that the high ROS levels exhibited on Days 7-11, 15, and 
19 are a function of high glucose concentrations in the media, ROS levels should be 
determined in adipocytes treated with low glucose media (5mM) (plasma homeostatic 
glucose concentrations). 
As adipocytes age they accumulate ROS 7.  In this study the source of free 
radical formation was designed to be endogenous, stemming from the oxidation of 
glucose from the high glucose medium (25mM), and not as an exogenous source 
utilized in previous studies 7,15. Typically, 3T3-L1 cells are differentiated in a high glucose 
medium, mimicking hyperglycemic conditions similar to what is seen in pre-diabetic 
subjects.  Previous research has shown that preadipocytes differentiated in either high 
or low glucose medium display differences in insulin sensitivity. Lin et al. (2005) showed 
that differentiation in a high glucose medium induced severe insulin resistance when 
compared to cells differentiated in a low glucose medium 7.  Moreover, an increased 
level of ROS in adipose tissue is associated with the onset of diabetes 13.  As ROS are 
produced endogenously, the free radicals take the form of the superoxide anion, 
hydrogen peroxide, or the peroxyl radical.  Endogenously there are multiple point 
sources of these free radicals; to understand which source is contributing to the level of 
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ROS generation would lead to a better understanding of how ROS are involved in insulin 
resistance onset.   
The insulin signaling cascade promotes glucose uptake in adipocytes and stores 
it as triacylglycerol.  The lipid content within the adipocyte is indicative of insulin 
sensitivity.  As adipocytes increase their lipid deposits, multiple smaller lipid droplets 
indicate sensitivity to insulin signaling, while larger lipid droplets are indicative of insulin 
resistance.  Day 10 adipocytes have small lipid droplets and very few large droplets; 
conversely Day 15 adipocytes have amassed more small lipid droplets, but also have 
more large lipid droplets (figure 6, table 1).  The effect of ROS on lipid droplet formation 
has not been observed previously.  Insulin sensitive adipocytes have smaller lipid 
droplets, and high levels of ROS (figure 3).  As adipocytes become insulin resistant the 
level of ROS fluctuate; at Day 15 the ROS levels are relatively high (figure 3). 
Antioxidants ascorbic acid and α-tocopherol were employed to suppress ROS 
levels and determine the role of ROS in the development of insulin resistance.  The 
addition of ascorbic acid or α-tocopherol significantly decreased ROS levels at Day 10 
and 15 (figure 5).  Though the adipocytes are becoming insulin resistant, they are not 
resistant to the antioxidant effects of ascorbic acid or α-tocopherol (figure 5).  As insulin 
resistance occurs there is a difference in the activation and suppression of crucial insulin 
signaling proteins (table 2).  Previously, as indicated 
 by Lin et al., IRS-1 is activated when phosphorylated on Tyr608/632 7.  However, 
decreased ROS levels greatly increased phosphorylation of IRS-1 and AKT on both Day 
10 and 15 equally (figure 9, 10).  Once quantified it was evident that decreased ROS 
levels do not have a significant effect on lipid accumulation (figure 7, table 1).   
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Since ascorbic acid is a polar molecule, it is taken up into the cell through 
passive, facilitative, and active diffusion.  In adipocytes it is transported into the cell via 
dehydroascorbic acid-facilitative diffusion via the GLUT1, 3, and 4 transporters and has 
been found to be competitive with glucose 23.  As we see in figure 4, as the 
concentrations of ascorbic acid treatment increase, the level of ROS plateau until Day 15 
with 500 µM treatment. The spike in ROS levels at this day may be attributed to the pro-
oxidant qualities of ascorbic acid at high concentrations (figure 4c) 48.  However, the 
lower concentrations were sufficient to induce a significant reduction of ROS levels and 
allowed us to examine how lowered levels of ROS affect adipocytes. 
With antioxidant treatment GLUT4 expression was observed not to decrease but 
remained consistent from Day 10 to 15 (figure 8).  This finding indicates that ROS are a 
major player in the regulation of GLUT4 expression, and that high levels of ROS are 
detrimental to the insulin sensitivity of adipocytes.  ROS have been identified as playing 
a role in the development of insulin resistance; yet it is difficult to determine the exact 
mechanism it works through.  Here we have demonstrated that ROS do play a role in 
suppression the activation of IRS-1 and AKT (table 2).  We also have identified that ROS 
do not have an integral role in the accumulation and storage of lipid.  By decreasing 
ROS levels we observed consistent expression of GLUT4 in adipocytes that otherwise 
would have developed insulin resistance. 
When studying the effects of ROS it is also important to study antioxidant 
enzyme activity.  Future studies that concentrate on the activity of antioxidant enzymes 
as ROS levels increase (catalase, glutathione peroxidase, SOD) could clarify when 
oxidative stress is occurring in adipocytes as insulin resistance is developing. Also, 
better methods of measuring ROS levels and source points of ROS in cells are needed 
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to understand a more accurate picture of the molecular mechanism occurring at the 
onset of insulin resistance.  Using antioxidants to decrease ROS levels has been useful 
for this study, however clarification of how ascorbic acid and α-tocopherol are 
transported into cells would result in a better understanding of how much is transported 
into adipocytes and if increased application of these antioxidants results in increased 
antioxidant function.  Moreover, N-acetyl cysteine (NAC) or another strong antioxidant 
may give more defined results as to how decreased ROS levels affect insulin signaling.  
While most clinical studies have been inclusive when treating insulin resistant individuals 
with antioxidants, this may have been due to the fact that treatment was administered 
after the onset of insulin resistance.  As we have seen here antioxidant treatment 
allowed maintenance of insulin sensitivity in high glucose conditions.  Though we did not 
look at recovery of insulin sensitivity in untreated Day 15 adipocytes, we did observe the 
maintenance of insulin sensitivity with antioxidant treatment when comparing the 
analysis of Day 15 to untreated Day 15 adipocytes.   
In conclusion, the regulation and development of insulin resistance in 3T3-L1 
adipocytes is much more complex and influenced by more than increased levels of ROS, 
however ROS do play a major role in its development through GLUT4 suppression.  
Here we have demonstrated that exogenous and endogenous ROS influence insulin 
resistance via different mechanisms (table 3).  The addition of exogenous ROS inhibits 
phosphorylation of IRS-1 whereas when looking at endogenous ROS levels this is 
unaffected (table 3).  The development of insulin resistance is better thought of as a 
continuing process, not a state, as the signaling molecules and ROS levels are in 
constant flux from the trend seen in the levels of ROS.  Further examination of how 
endogenous ROS effect insulin signaling will allow for a more comprehensive 
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understanding on the mechanism behind insulin resistance development.  When 
diagnosed with insulin resistance or pre-diabetes, exercise and a healthy diet can help to 
combat/reverse this diagnosis.  This continuous process that is insulin resistance is best 
recognized and responded to quickly.   
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APPENDIX A  
TABLES 
 
Table 1. Frequency of lipid droplets sized by diameter.  Lipid droplet diameter was 
measured and categorized in 20 adipocytes per treatment and imaged at 100X using 
light microscopy.   
 
 
 Day 10 Day 15 
Diameter <6.25μm 6.25-
12.5μm 
12.5-
25μm 
>25μm <6.25μm 6.25-
12.5μm 
12.5-
25μm 
>25μm 
Vehicle 
 
20 18 4 0 20 17 9 0 
Ascorbic 
Acid 
20 14 10 1 20 13 4 0 
α-
tocopherol 
20 15 1 0 20 18 9 1 
 
 
Table 2. Characteristics of insulin sensitive and insulin resistant adipocytes.  
Comparative depiction representing the differences of adipocyte physiology and how 
endogenous, exogenous, and scavenged ROS influence insulin signaling.  
 
 
Day Day 10 Day 15 
Antioxidant 
Treatment - + - + 
Glucose 
Uptake 
Good Good Poor Good 
GLUT4 High 
expression 
High 
expression 
Low expression High 
expression 
IRS-1 Phosphorylated Increased 
phosphorylation 
Phosphorylated Increased 
phosphorylation 
AKT Phosphorylated Increased 
phosphorylation 
Increased 
phosphorylation 
Increased 
phosphorylation 
Lipid 
Droplet 
Size 
Small and large 
droplets 
Small and large 
droplets 
Increased lipid 
storage 
Increased lipid 
storage 
ROS 
Levels 
High Low High Low 
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Table 3. Comparison of endogenously produced and exogenously added ROS.  
Summary of differences between previous studies examining the effects of added 
exogenous, H2O2 and our study examining endogenously produced ROS on insulin 
signaling and sensitivity 5,7,15,18. 
 
 
Source of ROS Exogenous Endogenous 
Glucose Uptake Poor Poor 
GLUT4 Low expression Low expression 
IRS-1 Suppressed Activation No change in activation 
AKT Phosphorylation Decreased  Increased 
ROS Levels High High 
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APPENDIX B 
 
FIGURES 
 
 
 
Figure 1. Antioxidant mechanism.  Schematic representation of free radical formation 
and the antioxidant response mechanism.  Vitamin E and C mimic antioxidant enzymes 
glutathione peroxidase and reductase respectively.  Superoxide anion (O2•-), Hydrogen 
peroxide (H2O2), Hydroxyl Radical (OH•-), Glutathione reduced form (GSH), and 
Glutathione oxidized form (GSSH).  
- 
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Figure 2. Production of ROS in adipocytes.  Schematic representation of the effects 
of exogenous ROS and the proposed effects of increased endogenous ROS on the 
development of insulin resistance. 
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Figure 3. Production of ROS in mature 3T3-L1 adipocytes.  Mature adipocytes were 
assayed for ROS (O2●-) production by NBT reduction every other day from Day 7 to 21. 
Cells were treated with 0.2% NBT for 90 min in the dark. NBT was reduced to formazan 
by ROS and dissolved in 50% acetic acid. The absorbance was determined at 560 nm.  
Results are representative of 3 independent experiments.  (* p=0.032) 
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Figure 4. Determination of the effective concentration of ascorbic acid and α-
tocopherol for treatment of mature 3T3-L1 adipocytes.  Mature 3T3-L1 adipocytes 
were treated with ascorbic acid (0 to 1000 µM), α-tocopherol (0 to 1000 µM).  Viability 
was assessed by FLOW Cytometery with increasing concentrations of (a) ascorbic acid 
and (b) α-tocopherol.  Levels of ROS were measured via the NBT assay in the presence 
or absence of ascorbic acid (c), or α-tocopherol (d). (*p=0.04, ** p=0.017, † p=0.004, ‡ 
p=0.023)  
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Figure 5. Antioxidant treatment of 3T3-L1 adipocytes.  Mature adipocytes treated 
with 60 µM ascorbic acid or 40 µM α-tocopherol were measured for ROS levels using 
the NBT assay on D10 and D15. Results are representative of 3 independent 
experiments.  
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Figure 6. Lipid accumulation in 3T3-L1 adipocytes.  Day 7 adipocytes were either 
untreated or treated for 3 or 8 days with 60 µM ascorbic acid or 40 µM α-tocopherol.  
Unstained adipocytes were imaged on Days 10 and 15 on an AMG EVOSxl imaging 
station using phase contrast microscopy at 40X during differentiation.   
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   Day 10       Day 15 
Figure 7.  Lipid distribution by size.  Adipocytes were treated with vehicle (dH2O), 60 
µM ascorbic acid, or 40 µM α-tocopherol beginning at Day 7.  At Day 10 and 15 they 
were imaged on the AMG EVOSxl at 100X. Lipid droplets from 20 adipocytes per day 
and treatment were counted and categorized by size at 100X.  The percent distribution 
of lipid droplets by size was calculated and is displayed above.  
 
 
 
 
 
 
 
 
 
 
88%
90%
92%
94%
96%
98%
100%
dH2O Vit C Vit E dH2O Vit C Vit E
>25 um
12.5-25 um
6.25-12.5 um
<6.25 um
39 
 
 
 
 
Figure 8.  Expression of GLUT4 with ascorbic acid or α-tocopherol treatment.  Day 
7 3T3-L1 adipocytes were untreated (a) or treated for 3 to 8 days with either 60 µM 
ascorbic acid (b), or 40 µM α-tocopherol (c).  On day 10 or 15, cells were serum 
starvation for 4 hrs, and then either left untreated or treated with insulin (100 nM ) for 20 
min.  Cell lysates were analyzed by SDS-PAGE and then immunoblotted with antibodies 
to GLUT4 or pan-actin.  Results are representative of 3 independent experiments. 
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Figure 9.  Activation of IRS-1 with ascorbic acid or α-tocopherol treatment.  3T3-
L1 adipocytes were pretreated with either 60 µM ascorbic acid, 40 µM α-tocopherol, 
DMSO, or dH2O.  On day 10 or 15, cells were serum starvation for 4 hrs, and then 
either left untreated or treated with insulin (100 nM ) for 20 min.  Cell lysates were 
analyzed by SDS-PAGE and then immunoblotted with antibodies to IRS-1 pTYR608 or 
IRS-1. (b) Antioxidant treatment pIRS levels were normalized to corresponding Day and 
insulin stimulation levels shown in (a).  Results are representative of 3 independent 
experiments.   
 
41 
 
  
Figure 10. Activation of AKT with ascorbic acid and α-tocopherol treatment.  3T3-
L1 adipocytes were pretreated with either 60 µM ascorbic acid, 40 µM α-tocopherol, 
DMSO or dH2O. On day 10 or 15, adipocytes were serum starved for 4 hrs and either 
left untreated or  treated with  insulin (100 nM ) for 20 min.  Cell lysates were analyzed 
by SDS-PAGE and then immunoblotted with pAKT or AKT.  (b) Antioxidant treatment 
pAKT levels were normalized to corresponding Day and insulin stimulation levels shown 
in (a).  Results are representative of 3 independent experiments.  
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